ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,527Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 955

$1.34M Total Retail Price of All Prescriptions

Rank: 19 out of 955

584 Patients Receiving at Least One Drug in Part D
65% Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Arkansas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

13% of this provider’s 584 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

30% of this provider’s 584 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $47 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 833 365 165 S3 1 1
OMEPRAZOLE 681 472 120 2 5
LISINOPRIL 629 403 97 3 2
PRAVASTATIN SODIUM 587 402 96 4 11
POTASSIUM CHLORIDE 569 406 75 5 9
ATORVASTATIN CALCIUM 515 327 70 6 13
LEVOTHYROXINE SODIUM 492 352 70 7 3
FUROSEMIDE 483 382 85 8 7
METFORMIN HCL 382 257 56 9 8
MELOXICAM 381 200 80 10 15
NAMENDA 380 360 39 11 35
AMLODIPINE BESYLATE 373 279 49 12 6
CITALOPRAM HBR 344 267 60 13 16
LORAZEPAM 316 253 61 B 14 31
METOPROLOL SUCCINATE 316 251 40 14 23
NEXIUM 315 139 58 16 25
SIMVASTATIN 313 229 52 17 4
METOPROLOL TARTRATE 304 251 46 18 12
GEMFIBROZIL 302 153 48 19 102
CLOPIDOGREL 291 238 43 20 18
GABAPENTIN 288 175 44 21 10
ALENDRONATE SODIUM 270 213 37 22 51
ATENOLOL 255 170 38 23 21
WARFARIN SODIUM 249 212 29 24 19
CLONAZEPAM 241 85 33 B 25 32
CYMBALTA 224 155 22 26 43
PREDNISONE 209 121 96 27 47
HYDROCHLOROTHIAZIDE 203 146 32 28 14
FLUTICASONE PROPIONATE 202 112 42 29 38
DONEPEZIL HCL 192 181 25 30 33
ALPRAZOLAM 191 75 32 B 31 20
CARVEDILOL 186 140 33 32 27
CRESTOR 176 109 27 33 49
TRAMADOL HCL 154 88 45 34 17
NITROFURANTOIN MONO-MACRO 148 100 34 35 193
PROAIR HFA 147 60 40 36 36
DIAZEPAM 144 37 21 B 37 59
LAMOTRIGINE 143 118 20 38 173
DIOVAN 141 136* 18 39 57
TAMSULOSIN HCL 140 118 28 40 29
GALANTAMINE HBR 133 133 17 41 275
LYRICA 131 95 18 42 63
BENAZEPRIL HCL 129 93 15 43 88
BUSPIRONE HCL 127 98 17 44 117
SERTRALINE HCL 124 102 21 45 26
CYCLOBENZAPRINE HCL 124 22 32 R 45 54
AGGRENOX 124 111 15 45 151
ZOLPIDEM TARTRATE 115 73 28 48 24
TRAZODONE HCL 113 51 24 49 30
GLIPIZIDE 113 87 19 49 50
VENLAFAXINE HCL ER 112 55 14 51 98
PRAMIPEXOLE DIHYDROCHLORIDE 110 53 18 52 148
AZITHROMYCIN 110 70 87 52 41
MIRTAZAPINE 110 87 21 52 60
DETROL LA 106 90 13 55 140
ENDOCET 105 60 20 S2 56 312
RISPERIDONE 104 84 14 A 57 90
MORPHINE SULFATE ER 100 <11 <11 S2 58 112
IBUPROFEN 99 41 23 59 110
OXYCODONE HCL 95 <11 <11 S2 60 62
PAROXETINE HCL 94 32 16 61 68
AMLODIPINE BESYLATE-BENAZEPRIL 93 81 12 62 76
FLUOXETINE HCL 92 51 15 63 48
TIZANIDINE HCL 90 <11 19 64 65
NYSTATIN 88 50 37 65 153
ESCITALOPRAM OXALATE 86 41 11 66 46
CARISOPRODOL 86 18 14 R 66 64
FAMOTIDINE* 85 80* 14 68 67
JANUVIA 84 <11 <11 69 96
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 50 17 70 22
ALLOPURINOL 80 54 12 71 34
CARBIDOPA-LEVODOPA 80 53 11 71 116
OLANZAPINE 79 <11 <11 A 73 134
ISOSORBIDE MONONITRATE ER 77 72* 11 74 55
MONTELUKAST SODIUM 77 <11 <11 74 61
OXYCODONE HCL-ACETAMINOPHEN 77 18 19 S2 74 89
VALSARTAN-HYDROCHLOROTHIAZIDE 76 64 13 77 81
ADVAIR DISKUS 75 43 13 78 69
CELEBREX 73 43 17 79 105
SOTALOL 72 <11 <11 80 240
NITROSTAT 71 37 28 81 195
PROMETHAZINE HCL 70 27 25 R 82 85
CLONIDINE HCL 67 31 14 83 44
FENOFIBRATE* 66 <11 <11 84 83
NAPROXEN 66 <11 <11 84 78
VENTOLIN HFA 66 11 16 84 94
LEVOFLOXACIN 63 58* 45 87 77
LACTULOSE 63 <11 <11 87 189
ATENOLOL-CHLORTHALIDONE 63 <11 <11 87 165
GLYBURIDE-METFORMIN HCL 62 47 11 R 90 142
GLIPIZIDE ER 62 57* 13 90 91
TEKTURNA 61 <11 <11 92 346
SPIRONOLACTONE 61 <11 <11 92 71
DEXILANT 60 24 15 94 163
PREMARIN 60 30 12 R 94 141
METHADONE HCL 59 <11 <11 S2 96 114
DIGOXIN 58 <11 <11 97 137
DIGOX 57 <11 <11 98 86
LOVASTATIN 57 <11 <11 98 52
PANTOPRAZOLE SODIUM 56 41 14 100 42
OXYCONTIN 55 <11 <11 S2 101 158
AMITRIPTYLINE HCL 55 50* 12 R 101 45
VESICARE 54 <11 <11 103 167
FENTANYL 53 36 11 S2 104 109
NAMENDA XR 53 <11 <11 104 282
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 32 47 106 70
ZETIA 52 <11 <11 106 97
NASONEX 51 26 11 108 246
MEDROXYPROGESTERONE ACETATE 51 <11 <11 108 302
CEPHALEXIN 50 26 34 110 80
ENALAPRIL MALEATE 50 <11 <11 110 75
POLYETHYLENE GLYCOL 3350 50 24 17 110 72
PIOGLITAZONE HCL 50 20 11 R 110 100
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.